Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
PLoS One ; 9(4): e95342, 2014.
Article in English | MEDLINE | ID: mdl-24736646

ABSTRACT

The sleep disorder narcolepsy is now considered a neurodegenerative disease because there is a massive loss of neurons containing the neuropeptide hypocretin/orexin (HCRT). In consequence, narcoleptic patients have very low cerebrospinal fluid (CSF) levels of HCRT. Studies in animal models of narcolepsy have shown the neurophysiological role of the HCRT system in the development of this disease. For example, the injection of the neurotoxin named hypocretin-2-saporin (HCRT2/SAP) into the lateral hypothalamus (LH) destroys the HCRT neurons, therefore diminishes the contents of HCRT in the CSF and induces narcoleptic-like behavior in rats. Transplants of various cell types have been used to induce recovery in a variety of neurodegenerative animal models. In models such as Parkinson's disease, cell survival has been shown to be small but satisfactory. Similarly, cell transplantation could be employed to implant grafts of HCRT cells into the LH or even other brain regions to treat narcolepsy. Here, we report for the first time that transplantation of HCRT neurons into the LH of HCRT2/SAP-lesioned rats diminishes narcoleptic-like sleep behavior. Therefore, cell transplantation may provide an effective method to treat narcolepsy.


Subject(s)
Behavior, Animal , Cell Transplantation , Intracellular Signaling Peptides and Proteins/metabolism , Narcolepsy/therapy , Neurons/metabolism , Neurons/transplantation , Neuropeptides/metabolism , Sleep , Animals , Hypothalamus/pathology , Male , Narcolepsy/pathology , Narcolepsy/physiopathology , Orexins , Rats , Rats, Wistar , Wakefulness
2.
Neuroscience ; 183: 134-43, 2011 Jun 02.
Article in English | MEDLINE | ID: mdl-21435382

ABSTRACT

Orexins (hypocretins) are peptide neurotransmitters produced by a small group of neurons located exclusively in the lateral hypothalamus (LH). Orexins modulate arousal, and as a result, have profound effects on feeding behavior and the sleep-wake cycle. Loss of orexin producing neurons leads to a narcoleptic phenotype, characterized by sudden transitions from vigilance to rapid eye movement (REM) sleep (direct transition to REM, DREM) observed in electroencephalogram (EEG) and electromyogram (EMG) recordings. In this study, we demonstrate that mice lacking the basic helix-loop-helix transcription factor O/E3 (also known as ebf2) have a decrease in orexin-producing cells in the LH, in addition to a severely impaired orexinergic innervation of the pons. These changes in the orexinergic circuit of O/E3-null animals induce a narcoleptic phenotype, similar to the one arising in orexin-deficient and orexin-ataxin-3 mice. Taken together, our results suggest that O/E3 plays a central role during the establishment of a functional orexinergic circuit by controlling the expression of essential hypothalamic neurotransmitter and the correct development of the nerve fibers arising from the hypothalamus. This is the first report regarding the narcolepsy-cataplexy syndrome in O/E3-null mice, which adds the importance of transcription factors in the regulation of neural subpopulations that control the sleep-wake cycle.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/deficiency , Narcolepsy/genetics , Narcolepsy/physiopathology , Animals , Arousal/drug effects , Brain/pathology , Catalepsy , Cell Count , Circadian Rhythm/physiology , Disease Models, Animal , Electroencephalography , Electromyography , Gene Expression Regulation/genetics , Guinea Pigs , Intracellular Signaling Peptides and Proteins/metabolism , Intracellular Signaling Peptides and Proteins/therapeutic use , Mice , Mice, Inbred C57BL , Mice, Knockout , Narcolepsy/drug therapy , Narcolepsy/pathology , Neurons/metabolism , Neuropeptides/metabolism , Neuropeptides/therapeutic use , Neurotransmitter Agents/therapeutic use , Orexins , Trans-Activators/genetics , Trans-Activators/metabolism
3.
Synapse ; 58(2): 95-101, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16088950

ABSTRACT

In 1989, we described a new autosomic-recessive myelin-mutant rat that develops a progressive motor syndrome characterized by tremor, ataxia, immobility episodes (IEs), epilepsy, and paralysis. taiep is the acronym of these symptoms. The rat developed a hypomyelination, followed by demyelination. At an age of 7-8 months, taiep rats developed IEs, characterized electroencephalographically by REM sleep-like cortical activity. In our study, we analyzed the ontogeny of gripping-induced IEs between 5 and 18 months, their dependence to light-dark changes, sexual dimorphism, and susceptibility to mild stress. Our results showed that IEs start at an age of 6.5 months, with a peak frequency between 8.5 and 9.5 months. IEs have two peaks, one in the morning (0800-1000 h) and a second peak in the middle of the night (2300-0100 h). Spontaneous IEs showed an even distribution with a mean of 3 IEs every 2 h. IEs are sexually dimorphic being more common in male rats. The IEs can be induced by gripping the rat by the tail or the thorax, but most of the IEs were produced by gripping the tail. Mild stress produced by i.p. injection of physiological saline significantly decreased IEs. These results suggested that IEs are dependent on several biological variables, which are caused by hypomyelination, followed by demyelization, which causes alterations in the brainstem and hypothalamic mechanisms responsible for the sleep-wake cycle regulation, producing emergence of REM sleep-like behavior during awake periods.


Subject(s)
Hereditary Central Nervous System Demyelinating Diseases/physiopathology , Movement Disorders/physiopathology , Sleep Wake Disorders/physiopathology , Age Factors , Animals , Brain Stem/pathology , Brain Stem/physiopathology , Cataplexy/genetics , Cataplexy/pathology , Cataplexy/physiopathology , Cerebral Cortex/physiopathology , Consciousness Disorders/genetics , Consciousness Disorders/pathology , Consciousness Disorders/physiopathology , Epilepsy/genetics , Epilepsy/pathology , Epilepsy/physiopathology , Female , Genetic Predisposition to Disease/genetics , Hereditary Central Nervous System Demyelinating Diseases/genetics , Hereditary Central Nervous System Demyelinating Diseases/pathology , Hypothalamus/pathology , Hypothalamus/physiopathology , Male , Movement Disorders/genetics , Movement Disorders/pathology , Narcolepsy/genetics , Narcolepsy/pathology , Narcolepsy/physiopathology , Rats , Rats, Mutant Strains , Sex Characteristics , Sleep Paralysis/genetics , Sleep Paralysis/pathology , Sleep Paralysis/physiopathology , Sleep Wake Disorders/genetics , Sleep Wake Disorders/pathology , Stress, Psychological/genetics , Stress, Psychological/pathology , Stress, Psychological/physiopathology , Tremor/genetics , Tremor/pathology , Tremor/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL